Chinese english Germany Japanese Korea

5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside

5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside Struktur
460355-04-8
CAS-Nr.
460355-04-8
Englisch Name:
5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside
Synonyma:
5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside;5’-O-(4,4’-Dimethoxytrityl)-3-formylindole-2’-deoxyriboside;1H-Indole-3-carboxaldehyde, 1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-β-D-erythro-pentofuranosyl]-;1-{(2R,4S,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-tetrahydro-furan-2-yl}-1H-indole-3-carbaldehyde
CBNumber:
CB44672476
Summenformel:
C35H33NO6
Molgewicht:
563.65
MOL-Datei:
460355-04-8.mol
Request For Quotation

5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside Eigenschaften

Siedepunkt:
759.5±60.0 °C(Predicted)
Dichte
1.22±0.1 g/cm3(Predicted)
pka
13.97±0.60(Predicted)

Sicherheit

5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside Chemische Eigenschaften,Einsatz,Produktion Methoden

5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences 		+1-631-485-4226
inquiry@bocsci.com United States 19553 58
NewCan Biotech Limited 		+86-0571-86912261 +8613735419629
 sales@newcanbio.com China 9980 58
Zhengzhou Granlen Sciences, ltd. 0371-85513397
info@granlen.com China 1842 58
  • 5'-O-(4,4'-Dimethoxytrityl)-3-formylindole-2'-deoxyriboside
  • 1-{(2R,4S,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-tetrahydro-furan-2-yl}-1H-indole-3-carbaldehyde
  • 1H-Indole-3-carboxaldehyde, 1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-β-D-erythro-pentofuranosyl]-
  • 5’-O-(4,4’-Dimethoxytrityl)-3-formylindole-2’-deoxyriboside
  • 460355-04-8
Copyright 2019 © ChemicalBook. All rights reserved